Healthcare
How China rewrote the rules of drug innovation
In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, regulatory velocity becomes a binding constraint
‘Treating obesity for the next 100 years’: Ozempic-maker Novo Nordisk targets tripling of Apac patient base
By sales volumes for its GLP-1 drugs, the company’s largest markets in the region are Australia, Japan, South Korea and India
Singapore a ‘safe harbour’ amid global volatility with Singdollar set to gain: Julius Baer
The wealth manager urges investors to look to growth areas for portfolio diversification
ChatGPT’s AI healthcare push has a fatal flaw
More than 230 million people ask the app for health-related advice every week
CK Hutchison seeks US$30 billion valuation for retail unit Watson Group’s Q2 IPO: sources
Temasek Holdings, which holds a 25% stake, is seeking to exit its investment in the IPO
‘Hangzhou Six’ tech startup BrainCo is said to file for Hong Kong IPO
The startup is working with CICC and UBS on the share sale
Thomson Medical’s regional ambitions find a potent tonic in Vietnam
The Singapore group is targeting patient flows in the growing Mekong sub-region
How to help the world’s poor most in 2026
There are several policies that deliver astonishing returns even in today’s harsh fiscal reality
CEO of Salonpas maker seeks to take the 450 billion yen drug firm private
The Japanese government has been promoting cheaper generic medicines and pushing drugmakers to cut prices as its population ages
Sias calls on Singapore Paincare to clarify actions after failed privatisation bid
Move is in light of the impact the collapsed deal has on minority shareholders
